LENZ THERAPEUTICS, INC. Accumulated Other Comprehensive Income
LENZ THERAPEUTICS, INC. (LENZ) had Accumulated Other Comprehensive Income of -$629.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-11
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$629.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$450.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $242.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $227.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$629.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$450.00K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $242.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $227.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $38.00K 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $123.00K 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $196.00K 10-K · filed 2026-03-24 | |
| 2024-09-30 | $523.00K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | -$62.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$1.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $6.00K 10-K · filed 2025-03-19 | $0.00 10-K · filed 2024-02-27 |
| 2023-09-30 | -$95.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$271.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$469.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$1.05M 10-K · filed 2024-02-27 | |
| 2022-09-30 | -$1.60M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$1.03M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$309.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |